Mixed-Methods Approach: Impact of Clinical Consenter Diversity on Clinical Trials Enrollment
We find that consenter race and ethnicity are important for clinical trial diversity. Larger studies are needed to evaluate the generalizability of this finding.
Authors
- Jackelyn A. Alva-Ornelas
- Christina M. Vidal
- Alicia Ramírez Orellana (ORCID: https://orcid.org/0000-0001-6716-1560)
- Jerneja Tomšič (ORCID: https://orcid.org/0009-0007-0927-0428)
- Veronica Jones (ORCID: https://orcid.org/0000-0003-2084-6815)
- Ángeles Monge (ORCID: https://orcid.org/0000-0003-2242-7593)
- Ernest Martinez (ORCID: https://orcid.org/0000-0002-6326-4121)
- Kendrick Davis
- Nancy Sanchez
- Dana Aljaber (ORCID: https://orcid.org/0000-0003-1733-7999)
- Cristal Resto
- Angélica Sánchez (ORCID: https://orcid.org/0000-0002-5093-9134)
- Victoria L. Seewaldt (ORCID: https://orcid.org/0000-0002-7289-9268)
- Noé Rubén Chávez (ORCID: https://orcid.org/0000-0002-7768-0388)
- Nikita Jinna (ORCID: https://orcid.org/0000-0002-4068-2881)
- Ángela Reyes
- Vanessa Myriam Robles
Institutions
- University of California, Riverside (US)
- City of Hope (US)
- Charles R. Drew University of Medicine and Science (US)
Publication Details
- Journal
- Cancers
- Published
- 2025-03-20
- DOI
- https://doi.org/10.3390/cancers17061043
- Primary Topic
- Ethics in Clinical Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00